Protagonist Therapeutics, Inc. (PTGX)
149.50
-2.00
(-1.32%)
USD |
NASDAQ |
Aug 27, 16:00
149.45
-0.05
(-0.03%)
After-Hours: 20:00
Protagonist Therapeutics EPS Diluted (TTM) : 1.037 for June 30, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.037 |
| March 31, 2026 | -1.804 |
| December 31, 2025 | -2.043 |
| September 30, 2025 | 0.6333 |
| June 30, 2025 | 0.7125 |
| March 31, 2025 | 0.7606 |
| December 31, 2024 | 4.206 |
| September 30, 2024 | 2.666 |
| June 30, 2024 | 2.627 |
| March 31, 2024 | 2.449 |
| December 31, 2023 | -1.478 |
| September 30, 2023 | -2.615 |
| June 30, 2023 | -2.674 |
| March 31, 2023 | -2.834 |
| December 31, 2022 | -2.596 |
| September 30, 2022 | -2.668 |
| June 30, 2022 | -2.737 |
| March 31, 2022 | -2.588 |
| December 31, 2021 | -2.701 |
| September 30, 2021 | -2.411 |
| June 30, 2021 | -1.914 |
| March 31, 2021 | -1.819 |
| Date | Value |
|---|---|
| December 31, 2020 | -2.001 |
| September 30, 2020 | -2.158 |
| June 30, 2020 | -2.559 |
| March 31, 2020 | -3.150 |
| December 31, 2019 | -3.006 |
| September 30, 2019 | -2.945 |
| June 30, 2019 | -2.718 |
| March 31, 2019 | -1.945 |
| December 31, 2018 | -1.727 |
| September 30, 2018 | -1.304 |
| June 30, 2018 | -1.213 |
| March 31, 2018 | -1.693 |
| December 31, 2017 | -2.17 |
| September 30, 2017 | -2.69 |
| June 30, 2017 | -3.27 |
| March 31, 2017 | -2.825 |
| December 31, 2016 | -2.660 |
| September 30, 2016 | -2.145 |
| June 30, 2016 | -1.275 |
| March 31, 2016 | -0.8301 |
| March 31, 2015 | -0.1546 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Gilead Sciences, Inc. | -2.656 |
| Insmed, Inc. | -4.105 |
| Madrigal Pharmaceuticals, Inc. | -12.88 |
| AbbVie, Inc. | 3.537 |
| PTC Therapeutics, Inc. | -0.5938 |